The Blog

Red flags to watch, and the governance practices that make the difference

For non-EU manufacturers and formulators, appointing an Only Representative (OR) under Article 8 of EU REACH can be a strategic route to EU market access, business continuity and commercial independence. By centralising REACH registration responsibilities with an EU/EEA-based OR, companies can reduce reliance on individual EU importers, which are then regarded as downstream users for the covered substances once the arrangement is properly established and communicated.

What may appear to be a straightforward appointment is therefore a significant shift in the compliance chain. When well governed, the arrangement supports stable operations and compliance in the background. When governance is weak, however, gaps can develop gradually and remain unnoticed until a customer request, audit or regulatory question brings them into focus.

This article looks beyond the legal appointment to explore what effective OR management requires in practice, why early warning signs matter, and how the choice of a professional, experienced OR can support resilient compliance as business conditions evolve.

EU REACH defines the role, but not the operating model

Article 8 of EU REACH is clear on a legal basis. The OR must be established in the EU/EEA, have sufficient background in the practical handling of substances and related information, and keep relevant information up to date, including quantities imported and customers supplied.

Beyond that, the EU REACH Regulation says much less about how the role should be managed day to day. It does not prescribe how continuity should be maintained, how reporting should be structured, or how the OR should respond when supply chains, volumes, uses or customer structures change.

That practical gap matters because chemical regulatory compliance is not static. A registration may be in place, but the business reality behind it can continue to move. This is where experience, systems and governance become decisive.

This is why a best practice guidance from the Only Representatives Organisation (ORO) is useful in practice. By setting out expectations for responsible OR conduct, it helps companies benchmark whether their representative is operating with the level of rigor the role requires, beyond the minimum wording of Article 8.

Compliance is not something to “set and forget”

One of the most common misconceptions is that once an EU REACH registration is completed, the work is essentially done. In reality, EU REACH registration is only the starting point.

Volumes fluctuate, customers change, supply routes shift, substance classifications may be updated and uses can evolve. Dossier updates may become necessary also for other reasons. Over time, the assumptions behind a registration can therefore drift away from what is actually happening in the EU market.

A professional and experienced OR works steadily in the background to keep the compliance position aligned before small changes become bigger issues. At a minimum, the OR should maintain a clear and current view of:

• which substances and importers are covered
• how volumes and tonnage bands are evolving
• whether dossiers and records still reflect actual activity, or if updates have been required
• whether supply-chain changes affect the compliance position
• whether communication with the non-EU company, importers, consortiums and authorities remains consistent
• whether dossier updates are required either spontaneously, due to a lead registrant updates or due to an ECHA decision

When this works well, it is usually a good sign. Good OR management is often most visible in the absence of surprises.

What strong OR governance looks like in practice

In day-to-day work, the quality of an OR arrangement is usually reflected less in formal promises and more in how consistently the role is executed.

Mature OR under REACH arrangements tend to show the same characteristics:

• clear visibility of what is covered by the submitted registration and what is not
• up-to-date and consistent registration information
• proactive identification of changes, gaps or risks
• documentation that supports the actual supply-chain setup
• structured & transparent communication rather than ad hoc updates
• proper protection of confidential commercial information (e.g. using IT tools for volume and customer information), with processes that safeguard the client’s interests, reduce non-compliance risks and proactively mitigate risks arising from the ECHA evaluation process
• standard contractual provisions that allow for an orderly change of Only Representative, where required
• clear processes and backup support to keep work moving if key contacts change
• tracking dossier update requirements and executing updates in time to meet regulatory deadlines
• a dedicated contact point for regulatory queries, supported by prompt and reliable responses
• willingness to educate and train the client’s organisation to strengthen regulatory knowledge and improve communication with EU customers

These are not abstract qualities. They are the practical disciplines that help keep chemical regulatory compliance stable when business conditions change.

Where issues usually start

Weak OR arrangements rarely fail loudly at the beginning. More often, the warning signs appear in small operational gaps that are easy to overlook.

Common red flags include:

• unclear visibility of importer coverage
• outdated or inconsistent records lack of proactive and transparent communication or structure reporting
• slow or fragmented responses when questions arise
• documentation that does not fully match commercial reality
• no clear sense that one party is holding the full compliance picture
• ECHA evaluation decision letters that raise concerns about the quality of dossiers submitted by the OR acting as lead registrant

Individually, these issues may not appear critical. Together, they can create blind spots that only become visible under pressure, for example during a European Chemicals Agency (ECHA) inspection, Evaluation process or a customer request or a regulatory inquiry.

By that stage, fixes are often more difficult, more urgent and more disruptive than they would have been if the gaps had been addressed earlier.

Why periodic review matters

As businesses and regulatory requirements evolve, it is sensible to revisit whether the OR setup still fits the current operating model. This does not mean something is necessarily wrong. It simply recognises that supply chains, volumes, customer structures and regulatory expectations rarely stand still.

A structured review will typically ask whether:

• the OR has full visibility of current activity
• reporting and communication are working as expected
• dossiers and records reflect the current business reality
• the overall setup remains robust under today’s business conditions

Keeping continuity when OR arrangements change

Sometimes a review confirms that only small adjustments are needed. In other cases, the arrangement may no longer provide the level of visibility, responsiveness or control required.

What matters is that the OR system remains aligned with how the business operates today, not how it looked several years ago. Where responsibilities need to be transferred between Only Representatives, the key priority is continuity: ensuring that registrations, records, communications and importer coverage remain properly managed throughout the transition.

A broader pattern across REACH-like regulatory frameworks

This is not only an EU REACH-specific issue. OR-based compliance models are also used in other REACH-like regulatory frameworks, where non-domestic manufacturing/formulating companies rely on an appointed local entity to manage obligations on their behalf.

Across these systems, the same success factors tend to appear repeatedly:

• regulatory knowledge and technical competence
• company local operational capability and organization set-up
• transparency
• system maturity
• continuity
• reliability and reputation
• business understanding
• responsiveness when circumstances change

The regulatory label may differ, but the operational expectations are often very similar.

Final thought

An Only Representative can be easy to think of as a requirement on paper. In reality, the role sits much closer to the centre of chemical regulatory compliance governance than many companies initially assume.

It connects legal obligations, supply-chain reality and commercial continuity. That is why the key question is not simply whether an OR has been appointed.

The more important question is whether the OR arrangement is strong enough to keep chemical regulatory compliance aligned as the business and regulatory requirements evolve.

Looking for expert support with EU REACH registration or Only Representative (OR) services? Contact us at sales@reachlaw.fi. We would be happy to discuss with you!

More information on OR best practices can be found here.